ArticleScientific reports2025
Changes in corneal higher-order aberrations following PreserFlo MicroShunt implantation.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this retrospective study, we evaluated changes in corneal higher-order aberrations (HOAs) after PreserFlo MicroShunt (PFM) implantation and examined factors associated with the outcomes. We included 101 PFM implantations performed between February 2023 and June 2024. Visual acuity, intraocular pressure, corneal HOAs, and coma-like and spherical aberrations were analyzed preoperatively, at 1 week, and at 1, 2, and 3 months postoperatively. Generalized linear mixed models were used to analyze factors that might affect HOAs and other aberrations. Preoperatively, HOAs, coma-like aberrations, and spherical-like aberrations were 0.249 ± 0.192, 0.216 ± 0.180, and 0.109 ± 0.093 μm, respectively. Aberrations showed a significant increase up to 1 month postoperatively, peaking at 1 week, with values of 0.396 ± 0.210 μm, 0.346 ± 0.204 μm, and 0.173 ± 0.105 μm, respectively (all P < 0.001). The aberrations were no longer significantly greater than baseline at 2 and 3 months postoperatively. Analysis of risk factors suggested that post-implantation hypotony (≤ 5 mmHg) could influence corneal HOAs and coma-like aberrations. PFM implantation temporarily increased corneal HOAs, coma-like aberrations, and spherical aberrations, but these levels stabilized and had returned to preoperative levels by 2 months postoperatively. Postoperative hypotony was associated with increased corneal HOAs and coma-like aberrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.